Trial site
University of Michigan Kellogg Eye Center
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Retinitis pigmentosa9 trials
- Macular degeneration6 trials
- Diabetic eye disease1 trial
- Glaucoma1 trial
- High blood pressure1 trial
- Phase
- Phase 24 trials
- Phase 1/23 trials
- Phase 33 trials
- Early phase 11 trial
- Phase 11 trial
- Status
- Active, not recruiting7 trials
- Recruiting5 trials
- Completed3 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Ascidian Therapeutics, Inc2 trials
- PYC Therapeutics2 trials
- 4D Molecular Therapeutics1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Hoffmann-La Roche1 trial
- and 9 more
Running trials
Recruiting
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
Active, not recruiting
Recruiting
Active, not recruiting
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Active, not recruiting
Recruiting
Active, not recruiting
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration4 recruiting
- Retinitis pigmentosa2 recruiting
- Diabetic eye disease1 recruiting
- Glaucoma1 recruiting
- High blood pressure1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026